EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Interleukin‐6 and Oncostatin M Levels in Patients With Type 1 Diabetes and Its Relationship With Glycemic Indices

Mona Nourbakhsh, Farzaneh Rouhani, Maryam Razzaghy-Azar iD, Mitra Nourbakhsh iD, Vahid Saeedi iD, Mahdokht Mehramiz, Davoud Amirkashani iD, Arash Mohazzab iD, Taraneh Rezaee

Endocrinology, Diabetes & Metabolism · 2026-05 · 9 (3)

DOI: 10.1002/edm2.70179 ↗

At a glance

Journal article in Endocrinology, Diabetes & Metabolism, published online on 2026-03-31. Written by Mona Nourbakhsh and 8 co-authors. Institution: Department of Pediatrics Endocrinology and Metabolism, School of Medicine, Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehra…. Major MEDLINE topics: Diabetes Mellitus, Type 1, Interleukin-6, Oncostatin M, Glycemic Index. 21 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Type 1 diabetes mellitus (T1DM) is an autoimmune disorder characterised by progressive destruction of pancreatic β‐cells, in which inflammatory cytokines such as interleukin‐6 (IL‐6) and oncostatin M (OSM) play key roles. This study aimed to evaluate serum IL‐6 and OSM levels and their relationship with glycemic indices in children with T1DM.

Methods

In this cross‐sectional study, 80 children (40 with T1DM and 40 controls) aged 3–18 years were included. Exclusion criteria were congenital or inflammatory disorders and use of anti‐inflammatory drugs, corticosteroids, NSAIDs, antibiotics, lipid‐lowering agents, hypoglycemic drugs, herbal supplements, multivitamins, or special diets. Serum IL‐6, OSM, fasting blood sugar (FBS), and HbA1c were measured. Demographic and clinical data—including age, sex, growth percentiles, BMI percentile, blood pressure, duration of diabetes, and history of diabetic ketoacidosis (DKA)—were recorded. Logistic regression was used to identify predictors of glycemic indices, and ROC curve analysis assessed the diagnostic performance of OSM. Statistical significance was set at p < 0.05.

Results

Out of 80 subjects, the mean age was 10.62 (3.3) years in children with T1DM and 11.25 (3.6) years in controls, with a comparable gender distribution (male: 52.5% vs. 60%). Serum OSM levels were significantly higher in children with T1DM ( p < 0.001) and strongly predicted elevated HbA1c (adjusted OR = 3.06; 95% CI: 1.84–5.08) and FBS (adjusted OR = 1.70; 95% CI: 1.31–2.20). ROC analysis demonstrated a robust ability to discriminate T1DM from controls (AUC = 0.94; 95% CI: 0.89–0.99), with a cut‐off of OSM > 10.0675, yielding a sensitivity and specificity of 87.5%. IL‐6 levels did not differ significantly between groups but were higher in children with a history of DKA.

Conclusion

OSM may represent a sensitive and specific biomarker for distinguishing children with T1DM from healthy individuals, whereas IL‐6 appears more closely related to DKA‐associated inflammation.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 1Interleukin-6Oncostatin MGlycemic IndexHumansMaleFemaleChildChild, PreschoolAdolescentCross-Sectional StudiesBiomarkersCase-Control StudiesBlood GlucoseGlycated Hemoglobin

Author keywords

diabetic ketoacidosisglycemic indicesinterleukin‐6oncostatin Mpaediatricstype 1 diabetes mellitus

Substances

Interleukin-6Oncostatin MBiomarkersIL6 protein, humanBlood GlucoseGlycated HemoglobinOSM protein, human

Authors and institutions

  • Department of Pediatrics Endocrinology and Metabolism, School of Medicine, Ali Asghar Children's Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
  • Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
  • Department of Clinical Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

ORCID profiles: Maryam Razzaghy-Azar, Mitra Nourbakhsh, Vahid Saeedi, Davoud Amirkashani, Arash Mohazzab

Cite

APA

Nourbakhsh, M., Rouhani, F., Razzaghy-Azar, M., Nourbakhsh, M., Saeedi, V., Mehramiz, M., Amirkashani, D., Mohazzab, A., & Rezaee, T. (2026). Interleukin‐6 and Oncostatin M Levels in Patients With Type 1 Diabetes and Its Relationship With Glycemic Indices. Endocrinology, Diabetes & Metabolism, 9(3). https://doi.org/10.1002/edm2.70179

Vancouver

Nourbakhsh M, Rouhani F, Razzaghy-Azar M, Nourbakhsh M, Saeedi V, Mehramiz M, et al. Interleukin‐6 and Oncostatin M Levels in Patients With Type 1 Diabetes and Its Relationship With Glycemic Indices. Endocrinology, Diabetes & Metabolism. 2026;9(3). doi:10.1002/edm2.70179

BibTeX
@article{Nourbakhsh2026,
  author = {Nourbakhsh, Mona and Rouhani, Farzaneh and Razzaghy-Azar, Maryam and Nourbakhsh, Mitra and Saeedi, Vahid and Mehramiz, Mahdokht and Amirkashani, Davoud and Mohazzab, Arash and Rezaee, Taraneh},
  title = {Interleukin‐6 and Oncostatin M Levels in Patients With Type 1 Diabetes and Its Relationship With Glycemic Indices},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  volume = {9},
  number = {3},
  doi = {10.1002/edm2.70179}
}
Start for free →